ITFG1
gene geneOn this page
Also known as CDA08TIPLNKN-1
Summary
ITFG1 (integrin alpha FG-GAP repeat containing 1, HGNC:30697) is a protein-coding gene on chromosome 16q12.1, encoding T-cell immunomodulatory protein (Q8TB96). Modulator of T-cell function.
Located in extracellular exosome.
Source: NCBI Gene 81533 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 105 total — 1 pathogenic
- MANE Select transcript:
NM_030790
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30697 |
| Approved symbol | ITFG1 |
| Name | integrin alpha FG-GAP repeat containing 1 |
| Location | 16q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CDA08, TIP, LNKN-1 |
| Ensembl gene | ENSG00000129636 |
| Ensembl biotype | protein_coding |
| OMIM | 611803 |
| Entrez | 81533 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 14 protein_coding, 5 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000320640, ENST00000537184, ENST00000542691, ENST00000544001, ENST00000563350, ENST00000563730, ENST00000564825, ENST00000565262, ENST00000565940, ENST00000567957, ENST00000568047, ENST00000569551, ENST00000868205, ENST00000868206, ENST00000868207, ENST00000868208, ENST00000868209, ENST00000868210, ENST00000868211, ENST00000868212, ENST00000943052
RefSeq mRNA: 2 — MANE Select: NM_030790
NM_001305002, NM_030790
CCDS: CCDS10728, CCDS76862
Canonical transcript exons
ENST00000320640 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001404558 | 47460838 | 47461063 |
| ENSE00003481551 | 47313729 | 47313823 |
| ENSE00003500906 | 47454013 | 47454158 |
| ENSE00003516666 | 47161750 | 47161832 |
| ENSE00003521396 | 47237965 | 47238008 |
| ENSE00003536868 | 47258632 | 47258740 |
| ENSE00003545688 | 47311240 | 47311412 |
| ENSE00003572210 | 47158873 | 47158990 |
| ENSE00003579174 | 47154391 | 47155778 |
| ENSE00003584453 | 47452733 | 47452790 |
| ENSE00003590392 | 47162540 | 47162664 |
| ENSE00003607924 | 47218868 | 47218946 |
| ENSE00003630716 | 47375876 | 47375940 |
| ENSE00003639225 | 47365788 | 47365869 |
| ENSE00003665139 | 47260545 | 47260695 |
| ENSE00003670902 | 47459103 | 47459175 |
| ENSE00003691955 | 47428804 | 47428898 |
| ENSE00003784160 | 47451396 | 47451470 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 98.30.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 29.4827 / max 226.3850, expressed in 1815 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157242 | 19.2336 | 1807 |
| 157244 | 4.1663 | 1585 |
| 157245 | 3.6993 | 1592 |
| 157246 | 1.4624 | 1070 |
| 157243 | 0.5638 | 294 |
| 157241 | 0.3014 | 93 |
| 157239 | 0.0558 | 37 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 98.30 | gold quality |
| cortical plate | UBERON:0005343 | 97.97 | gold quality |
| endothelial cell | CL:0000115 | 97.70 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 97.66 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 97.16 | gold quality |
| decidua | UBERON:0002450 | 97.10 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.04 | gold quality |
| islet of Langerhans | UBERON:0000006 | 96.79 | gold quality |
| tibia | UBERON:0000979 | 96.79 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 96.66 | gold quality |
| stromal cell of endometrium | CL:0002255 | 96.35 | gold quality |
| rectum | UBERON:0001052 | 96.33 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 96.31 | gold quality |
| visceral pleura | UBERON:0002401 | 96.27 | gold quality |
| primary visual cortex | UBERON:0002436 | 95.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.84 | gold quality |
| heart right ventricle | UBERON:0002080 | 95.82 | gold quality |
| gall bladder | UBERON:0002110 | 95.81 | gold quality |
| parietal pleura | UBERON:0002400 | 95.65 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.65 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 95.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.58 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 95.54 | gold quality |
| adrenal gland | UBERON:0002369 | 95.50 | gold quality |
| frontal cortex | UBERON:0001870 | 95.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 95.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 95.42 | gold quality |
| pleura | UBERON:0000977 | 95.41 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.38 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
miRNA regulators (miRDB)
98 targeting ITFG1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
Literature-anchored findings (GeneRIF, showing 2)
- Alterations in the cellular levels of TIP influence the phosphorylation state of a specific protein substrate of ataxia-telangiectasia mutated (ATM)/ATM- and Rad3-related (ATR) kinases. (PMID:17384681)
- The interaction between RUVBL1 and ITFG1 is required for breast cancer cell collective invasion and progression. (PMID:28341484)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | itfg1 | ENSDARG00000075584 |
| mus_musculus | Itfg1 | ENSMUSG00000031703 |
| rattus_norvegicus | Itfg1 | ENSRNOG00000015843 |
| drosophila_melanogaster | CG7739 | FBGN0036509 |
| caenorhabditis_elegans | WBGENE00014023 |
Protein
Protein identifiers
T-cell immunomodulatory protein — Q8TB96 (reviewed: Q8TB96)
Alternative names: Integrin-alpha FG-GAP repeat-containing protein 1, Linkin
All UniProt accessions (5): Q8TB96, F5GXC5, H3BQ64, H3BUJ1, I3L1X7
UniProt curated annotations — full annotation on UniProt →
Function. Modulator of T-cell function. Has a protective effect in graft versus host disease model.
Subunit / interactions. Interacts with RUVBL1, RUVBL2 and alpha-tubulin.
Subcellular location. Secreted. Membrane.
Tissue specificity. Ubiquitously expressed.
Similarity. Belongs to the TIP family.
RefSeq proteins (2): NP_001291931, NP_110417* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013517 | FG-GAP | Repeat |
| IPR024881 | Tip | Family |
| IPR028994 | Integrin_alpha_N | Homologous_superfamily |
| IPR057089 | C2_TIP | Domain |
Pfam: PF13517, PF23122
UniProt features (16 total): glycosylation site 12, signal peptide 1, chain 1, transmembrane region 1, repeat 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TB96-F1 | 89.87 | 0.76 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (12): 188, 226, 243, 353, 371, 482, 36, 95, 139, 146, 151, 176
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 126 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP, PAX4_01, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, NRF2_01, MCCLUNG_COCAINE_REWARD_5D, ACEVEDO_LIVER_CANCER_UP, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, HAMAI_APOPTOSIS_VIA_TRAIL_UP, ELK1_02, HORIUCHI_WTAP_TARGETS_UP, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (4): plasma membrane (GO:0005886), extracellular exosome (GO:0070062), extracellular region (GO:0005576), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| membrane | 1 |
| cell periphery | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
1554 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ITFG1 | TIPIN | Q9BVW5 | 769 |
| ITFG1 | LCK | P06239 | 577 |
| ITFG1 | RTKN | Q9BST9 | 550 |
| ITFG1 | TMEM179B | Q7Z7N9 | 524 |
| ITFG1 | TAX1BP3 | O14907 | 507 |
| ITFG1 | PHKB | Q93100 | 503 |
| ITFG1 | CHTF18 | Q8WVB6 | 493 |
| ITFG1 | DENND5B | Q6ZUT9 | 471 |
| ITFG1 | MTCL2 | O94964 | 442 |
| ITFG1 | LY6G6C | O95867 | 440 |
| ITFG1 | SLC24A3 | Q9HC58 | 433 |
| ITFG1 | CNTN2 | P78432 | 416 |
| ITFG1 | ZMAT4 | Q9H898 | 400 |
| ITFG1 | LNPK | Q9C0E8 | 395 |
| ITFG1 | TM7SF3 | Q9NS93 | 394 |
IntAct
98 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IL13RA2 | CHEK1 | psi-mi:“MI:0914”(association) | 0.640 |
| SLC39A5 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.640 |
| TMEM30B | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| CD1B | TOR1B | psi-mi:“MI:0914”(association) | 0.530 |
| CLEC4A | SEMA7A | psi-mi:“MI:0914”(association) | 0.530 |
| PICK1 | ILVBL | psi-mi:“MI:0914”(association) | 0.530 |
| HLA-DPA1 | TYW5 | psi-mi:“MI:0914”(association) | 0.530 |
| PCDHGB1 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.530 |
| VAMP5 | NBAS | psi-mi:“MI:0914”(association) | 0.530 |
| CD70 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| TNFSF8 | LGALS8 | psi-mi:“MI:0914”(association) | 0.530 |
| AMHR2 | FKBP5 | psi-mi:“MI:0914”(association) | 0.530 |
| CHRNA4 | FZD6 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM106A | B4GALT3 | psi-mi:“MI:0914”(association) | 0.530 |
| ANKH | FAM234B | psi-mi:“MI:0914”(association) | 0.530 |
| CDC73 | ITFG1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ITFG1 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.370 |
| HMOX2 | ITFG1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ITFG1 | MRPL44 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NUDT3 | ITFG1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SERBP1 | ITFG1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TAF1D | ITFG1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ITFG1 | TNFRSF14 | psi-mi:“MI:0915”(physical association) | 0.370 |
| psi-mi:“MI:0914”(association) | 0.350 | ||
| HLA-DPA1 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (569): ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-MS), ITFG1 (Affinity Capture-RNA), ITFG1 (Affinity Capture-MS), ITFG1 (Synthetic Lethality), SDF2L1 (Affinity Capture-MS), CANX (Affinity Capture-MS)
ESM2 similar proteins: B6JY29, G5ED65, H2KZU7, O01811, O16715, O44386, O45657, O45879, O59759, O61460, O64758, P30639, P34389, P46555, P47014, P86956, P90754, P90755, P91550, Q03600, Q04833, Q09216, Q09417, Q10659, Q18253, Q18331, Q18600, Q19127, Q19187, Q19617, Q19981, Q23316, Q24247, Q25410, Q5QQ52, Q60PR7, Q626H5, Q754Q4, Q7JKY3, Q7RRM4
Diamond homologs: Q8R4E1, Q8TB96, Q95KC8, Q99KW9, Q8I3H7, P30639, Q7RRM4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 132 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| adaptive immune response | 10 | 7.5× | 7e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
105 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 688122 | GRCh37/hg19 16q12.1(chr16:47258287-47662546)x1 | Pathogenic |
SpliceAI
4108 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:47161829:TAGA:T | acceptor_gain | 1.0000 |
| 16:47161833:C:CC | acceptor_gain | 1.0000 |
| 16:47162662:CAG:C | acceptor_gain | 1.0000 |
| 16:47218861:GTCTT:G | donor_loss | 1.0000 |
| 16:47218862:TCTTA:T | donor_loss | 1.0000 |
| 16:47218863:CTTA:C | donor_loss | 1.0000 |
| 16:47218864:TTA:T | donor_loss | 1.0000 |
| 16:47218865:TA:T | donor_loss | 1.0000 |
| 16:47218866:A:AG | donor_loss | 1.0000 |
| 16:47218867:CCTG:C | donor_loss | 1.0000 |
| 16:47218942:AAGGG:A | acceptor_gain | 1.0000 |
| 16:47218943:AGGG:A | acceptor_gain | 1.0000 |
| 16:47218944:GGG:G | acceptor_gain | 1.0000 |
| 16:47218945:GG:G | acceptor_gain | 1.0000 |
| 16:47218946:GCT:G | acceptor_loss | 1.0000 |
| 16:47218947:C:A | acceptor_loss | 1.0000 |
| 16:47218947:C:CC | acceptor_gain | 1.0000 |
| 16:47218948:T:A | acceptor_loss | 1.0000 |
| 16:47237963:A:AC | donor_gain | 1.0000 |
| 16:47237964:C:CC | donor_gain | 1.0000 |
| 16:47238009:C:CC | acceptor_gain | 1.0000 |
| 16:47260543:A:AC | donor_gain | 1.0000 |
| 16:47260544:C:CC | donor_gain | 1.0000 |
| 16:47260544:CAT:C | donor_gain | 1.0000 |
| 16:47311237:TACC:T | donor_loss | 1.0000 |
| 16:47311238:A:AC | donor_gain | 1.0000 |
| 16:47311238:A:C | donor_loss | 1.0000 |
| 16:47311238:ACCTT:A | donor_gain | 1.0000 |
| 16:47311239:C:CC | donor_gain | 1.0000 |
| 16:47311239:CCTT:C | donor_gain | 1.0000 |
AlphaMissense
4061 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:47155731:A:C | F609L | 1.000 |
| 16:47155731:A:T | F609L | 1.000 |
| 16:47155732:A:C | F609C | 1.000 |
| 16:47155733:A:G | F609L | 1.000 |
| 16:47155737:A:C | F607L | 1.000 |
| 16:47155737:A:T | F607L | 1.000 |
| 16:47155738:A:C | F607C | 1.000 |
| 16:47155738:A:G | F607S | 1.000 |
| 16:47155739:A:G | F607L | 1.000 |
| 16:47155756:C:G | R601P | 1.000 |
| 16:47158920:A:G | C578R | 1.000 |
| 16:47158931:A:G | L574P | 1.000 |
| 16:47158931:A:T | L574H | 1.000 |
| 16:47158940:G:T | A571D | 1.000 |
| 16:47158976:A:G | L559P | 1.000 |
| 16:47158987:C:A | W555C | 1.000 |
| 16:47158987:C:G | W555C | 1.000 |
| 16:47158989:A:G | W555R | 1.000 |
| 16:47158989:A:T | W555R | 1.000 |
| 16:47161780:A:T | V544D | 1.000 |
| 16:47161786:A:G | L542P | 1.000 |
| 16:47161792:G:A | S540F | 1.000 |
| 16:47161793:A:G | S540P | 1.000 |
| 16:47161798:G:T | P538Q | 1.000 |
| 16:47161799:G:A | P538S | 1.000 |
| 16:47161799:G:T | P538T | 1.000 |
| 16:47161801:A:G | I537T | 1.000 |
| 16:47161801:A:T | I537N | 1.000 |
| 16:47162585:A:C | F511L | 1.000 |
| 16:47162585:A:T | F511L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000014357 (16:47315865 A>T), RS1000025616 (16:47341959 G>T), RS1000035660 (16:47158119 G>A), RS1000050951 (16:47183444 G>A,C), RS1000069112 (16:47243823 G>A), RS1000077929 (16:47342332 T>C), RS1000089556 (16:47330916 A>G), RS1000115988 (16:47178211 C>G,T), RS1000118745 (16:47286619 G>A), RS1000130421 (16:47173767 G>A,C,T), RS1000144621 (16:47239289 C>G), RS1000162716 (16:47319675 C>T), RS1000167415 (16:47229291 A>T), RS1000193090 (16:47365011 C>T), RS1000200702 (16:47410955 C>T)
Disease associations
OMIM: gene MIM:611803 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression, increases expression | 2 |
| Valproic Acid | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | decreases expression, affects cotreatment | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| abrine | decreases expression | 1 |
| picoxystrobin | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | decreases methylation | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Dimethyl Sulfoxide | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lead | affects expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Rotenone | increases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1UT | Abcam HeLa ITFG1 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.